XYL · Xylem Inc.
$119.68
-0.64 (-0.53%)
At close · Aug 14
Market Cap
$28.09B
Shares
233.49M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$453,000,000
as of 2026-06-30
Program Utilization
69.8%
$1,047,000,000 used of $1,500,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-25 | $1,500,000,000 | $453,000,000 | 2026-06-30 | — | 10-Q , filed 2026-07-28 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-06-30 YTD | $1,243,000,000 | 10-Q, filed 2026-07-28 | ||
| 2025-12-31 | $15,000,000 | 10-K, filed 2026-02-25 | ||
| 2024-12-31 | $20,000,000 | 10-K, filed 2026-02-25 | ||
| 2023-12-31 | $25,000,000 | 10-K, filed 2026-02-25 | ||
| 2022-12-31 | $52,000,000 | 10-K, filed 2025-03-03 | ||
| 2021-12-31 | $68,000,000 | 10-K, filed 2024-02-28 | ||
| 2020-12-31 | $61,000,000 | 10-K, filed 2023-02-24 | ||
| 2019-12-31 | $40,000,000 | 10-K, filed 2022-02-25 | ||
| 2018-12-31 | $59,000,000 | 10-K, filed 2021-02-26 | ||
| 2017-12-31 | $25,000,000 | 10-K, filed 2020-02-28 | ||
| 2016-12-31 | $4,000,000 | 10-K, filed 2019-02-22 | ||
| 2015-12-31 | $179,000,000 | 10-K, filed 2018-02-23 | ||
| 2014-12-31 | $134,000,000 | 10-K, filed 2017-02-23 | ||
| 2013-12-31 | $73,000,000 | 10-K, filed 2016-02-26 | ||
| 2012-12-31 | $13,000,000 | 10-K, filed 2015-02-26 | ||
Key facts
CIK
1524472
CUSIP
98419M100
13F (30d)
1006 filings
972 filers
Visit website
Investor relations